Boxer Capital as of June 30, 2024
Portfolio Holdings for Boxer Capital
Boxer Capital holds 61 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 8.7 | $166M | 4.3M | 38.81 | |
| Springworks Therapeutics (SWTX) | 6.8 | $129M | 3.4M | 37.67 | |
| Cytokinetics Com New (CYTK) | 6.0 | $114M | 2.1M | 54.18 | |
| Merus N V (MRUS) | 5.9 | $112M | 1.9M | 59.17 | |
| Tyra Biosciences (TYRA) | 5.4 | $103M | 6.4M | 15.99 | |
| Sarepta Therapeutics (SRPT) | 5.4 | $103M | 650k | 158.00 | |
| Nuvalent Inc-a (NUVL) | 4.5 | $85M | 1.1M | 75.86 | |
| Ideaya Biosciences (IDYA) | 4.1 | $77M | 2.2M | 35.11 | |
| BeiGene Sponsored Adr | 3.8 | $71M | 500k | 142.67 | |
| Avidity Biosciences Ord (RNA) | 3.7 | $71M | 1.7M | 40.85 | |
| Tango Therapeutics (TNGX) | 3.7 | $70M | 8.2M | 8.58 | |
| Apellis Pharmaceuticals (APLS) | 3.5 | $66M | 1.7M | 38.36 | |
| Iteos Therapeutics (ITOS) | 2.3 | $44M | 2.9M | 14.84 | |
| Argenx SE Sponsored Adr (ARGX) | 2.3 | $43M | 100k | 430.04 | |
| Akero Therapeutics (AKRO) | 2.1 | $39M | 1.7M | 23.46 | |
| Nkarta (NKTX) | 1.7 | $33M | 5.6M | 5.91 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $33M | 1.3M | 25.06 | |
| Axsome Therapeutics (AXSM) | 1.7 | $32M | 400k | 80.50 | |
| Rocket Pharmaceuticals (RCKT) | 1.7 | $32M | 1.5M | 21.53 | |
| Fate Therapeutics (FATE) | 1.4 | $27M | 8.2M | 3.28 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.4 | $27M | 600k | 44.29 | |
| Third Harmonic Bio (THRD) | 1.4 | $26M | 2.0M | 13.00 | |
| Geron Corporation (GERN) | 1.3 | $25M | 6.0M | 4.24 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $24M | 1.6M | 15.23 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $23M | 600k | 38.99 | |
| Immunovant (IMVT) | 1.1 | $22M | 825k | 26.40 | |
| Kura Oncology (KURA) | 1.1 | $21M | 1.0M | 20.59 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $19M | 1.6M | 11.78 | |
| Eliem Therapeutics (CLYM) | 1.0 | $19M | 2.6M | 7.11 | |
| Day One Biopharmaceuticals I (DAWN) | 0.9 | $16M | 1.2M | 13.78 | |
| Spyre Therapeutics Com New (SYRE) | 0.9 | $16M | 697k | 23.51 | |
| Arvinas Ord (ARVN) | 0.9 | $16M | 609k | 26.62 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $16M | 400k | 39.27 | |
| Enliven Therapeutics (ELVN) | 0.8 | $16M | 671k | 23.37 | |
| Prothena Corp SHS (PRTA) | 0.7 | $14M | 690k | 20.64 | |
| Replimune Group (REPL) | 0.7 | $14M | 1.5M | 9.00 | |
| Poseida Therapeutics I (PSTX) | 0.7 | $13M | 4.5M | 2.92 | |
| Century Therapeutics (IPSC) | 0.7 | $13M | 4.9M | 2.55 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $12M | 1.7M | 7.07 | |
| Relay Therapeutics (RLAY) | 0.6 | $12M | 1.8M | 6.52 | |
| Cullinan Oncology (CGEM) | 0.6 | $12M | 658k | 17.44 | |
| Prelude Therapeutics (PRLD) | 0.5 | $9.8M | 2.6M | 3.81 | |
| Allogene Therapeutics (ALLO) | 0.5 | $9.0M | 3.9M | 2.33 | |
| Sana Biotechnology (SANA) | 0.4 | $8.4M | 1.5M | 5.46 | |
| Jasper Therapeutics Com New (JSPR) | 0.4 | $7.9M | 350k | 22.70 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $7.0M | 650k | 10.82 | |
| Engene Holdings (ENGN) | 0.4 | $6.9M | 728k | 9.43 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $6.0M | 750k | 8.02 | |
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $2.9M | 1.5M | 1.90 | |
| Boundless Bio (BOLD) | 0.1 | $2.8M | 711k | 3.87 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.4M | 506k | 4.66 | |
| Absci Corp (ABSI) | 0.1 | $2.2M | 700k | 3.08 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.9M | 238k | 8.15 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $1.8M | 450k | 4.09 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $1.7M | 812k | 2.08 | |
| Atara Biotherapeutics | 0.1 | $1.4M | 166k | 8.50 | |
| Bioatla (BCAB) | 0.0 | $940k | 686k | 1.37 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $408k | 309k | 1.32 | |
| DBV Technologies S A Sponsored Adr | 0.0 | $200k | 250k | 0.80 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $43k | 267k | 0.16 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.1k | 67k | 0.02 |
